Friday, January 2, 2026 1/2/2026

Role of Glycosphingolipids in Kidney Disease in Diabetes and Obesity

Award Number: R01DK139676
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/20/2025
PERIOD OF PERFORMANCE END DATE: 11/30/2028

Group Awards By:

View Award Description

Role of Glycosphingolipids in Kidney Disease in Diabetes and Obesity - Obesity and diabetes continue to be leading causes of chronic kidney disease (CKD). In our models of diabetes and obesity, we have found increased renal glycosphingolipids which are associated with impaired mitochondrial function, increased inflammatory T cells (Th17 cells), and progression of renal disease. Hypothesis: We will test the hypothesis that increases in glucosylceramide composition play an important role in the pathogenesis and progression of kidney disease in obesity and diabetes. We propose that these lipids mediate impaired mitochondrial function and inflammation, which are important mediators of kidney disease. In Specific Aim 1, we will test the hypothesis that inhibition of glucosylceramide synthesis by employing a) podocyte or b) renal tubule specific inducible inhibition of glucosylceramide synthase (UGCG: UDP-Glucose Ceramide Glucosyltransferase) will prevent the progression of kidney disease in mouse models of A) obesity and B) diabetes. We will determine bulk lipid composition by LC-MS/MS and glomerular and tubular lipid alterations with fluoMALDI and CARS-SRS. We will determine and localize glomerular and tubular cell diversity, cell state, and gene regulation by multiomic interrogation with snRNA-seq and ATAC-seq integrated with spatial transcriptomics. In Specific Aim 2, we will test the hypothesis that reductions glucosylceramide levels will improve mitochondrial function (oxidative phosphorylation and/or fatty acid oxidation rate) and dynamics (fusion/fission and/or mitophagy) in mouse models of obesity and diabetes. We will determine mitochondrial function by measurement of oxidative phosphorylation, extracellular acidification, and fatty acid oxidation. We will determine ultrastructural changes in mitochondria by superresolution fluorescence microscopy and electron microscopy (TEM and SEM). We will determine mitochondrial fusion/fission by utilizing PhAMexcised mice and mitophagy by utilizing mito-QC mice. In Specific Aim 3, we will test the hypothesis that inhibition of proinflammatory TH17 cell-specific glucosylceramide synthase will decrease inflammation and result in improved kidney function in mouse models of obesity and diabetes. We will determine proinflammatory immune cells including Th17 cells by high- dimensional spectral flow cytometry.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $831,580 )
2026	2026	GEORGETOWN UNIVERSITY	MAIN CAMPUS	WASHINGTON	DC	20057	DISTRICT OF COLUMBIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	12/15/2025	NON-COMPETING CONTINUATION	$831,580
														Subtotal = $831,580

Issue Date FY: 2025 ( Subtotal = $830,500 )
2025	2025	GEORGETOWN UNIVERSITY	MAIN CAMPUS	WASHINGTON	DC	20057	DISTRICT OF COLUMBIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	1/17/2025	NEW	$830,500
														Subtotal = $830,500

Grand Total All Awards = $1,662,080

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of Glycosphingolipids in Kidney Disease in Diabetes and Obesity

Award Number: R01DK139676

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/20/2025

PERIOD OF PERFORMANCE END DATE: 11/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer